Phase 2
N=27
Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home
Alcohol-Related Disorders · Alcohol Drinking · Alcoholism · Alcohol Abuse · Alcohol Use Disorders
Bottom Line
View on ClinicalTrials.gov: NCT02885311 ↗Enrolled (actual)
27
Serious AEs
0.0%
Results posted
Oct 2023
Primary outcome: Primary: Weekly Change in Drinking — -11.4; -22.2; -39.6; -29.3 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 2
- Interventions
- Motivation Enhancement Therapy (Behavioral); Modified Behavioral Self-Control Therapy (Behavioral); Naltrexone (Drug); Brief Advice (Behavioral); Referral to specialty substance use disorder treatment (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Northwell Health
- Primary completion
- Oct 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Weekly Change in Drinking |
-11.4; -22.2; -39.6; -29.3 | — |
Summary
The purpose of this research study is to develop and test a care model to treat excessive drinking and alcohol use disorders in the primary care setting. The goal of this research study is to increase the identification and treatment of problem drinking in the primary care setting. Individuals will be asked to participate in this study because routine screening and assessment conducted at your primary care clinic indicates that you have recently exceeded healthy drinking limits as outlined by the National Institutes of Alcohol and Alcoholism.
Eligibility Criteria
Inclusion Criteria
- Exceed NIAAA weekly or daily guidelines
- receive care at the 865 clinic
- are fluent in English
- are willing to provide signed, informed consent to participate
- available to complete research follow-ups
- are able to read English at the eighth grade or higher level and show no evidence of significant cognitive impairment
Exclusion Criteria
- Meet DSM-V criteria for drug dependence other than for marijuana or nicotine
- on probation or parole
- have a serious psychiatric illness (e.g., psychotic disorder, bipolar disorder, severe major depression, etc.) that is likely to require pharmacologic treatment or that is currently treated with psychotropic medication; organic mood or mental disorders, or substantial suicide or violence risk
Data sourced from ClinicalTrials.gov (NCT02885311). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.